BUSINESS● LOWOct 2 · Oct 2, 2026, 7:09 AM
Novartis inks up to $7.8B deal with Abogen for RNA-encoded therapeutics
Seeking Alpha Tech · global
Novartis has signed a deal worth up to $7.8 billion with Abogen for RNA-encoded therapeutics. This represents a major investment and collaboration in the biotechnology and pharmaceutical sectors.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS32m agoNHAI to conduct technical study for two RoBs at KallumthazhamThe HinduBUSINESS36m agoStellantis to invest ₹4,000 cr, plan 12 India launches, triple market share by 2030The Hindu